首页 | 本学科首页   官方微博 | 高级检索  
检索        

MA与DA方案诱导缓解急性非淋巴细胞白血病的临床观察
引用本文:王璇,ZHANG Hui-ying,崔海鹏.MA与DA方案诱导缓解急性非淋巴细胞白血病的临床观察[J].中国现代医学杂志,2008,18(14).
作者姓名:王璇  ZHANG Hui-ying  崔海鹏
作者单位:北华大学附属医院,血液科,吉林,吉林,132011
摘    要:目的比较柔红霉素联合阿糖胞苷(DA)、米托蒽醌联合阿糖胞苷(MA)治疗急性非淋巴细胞白血病的疗效和不良反应。方法采用随机配对研究方法观察60例急性非淋巴细胞白血病的治疗效果和不良反应,一组29例采用MA方案,另一组31例对照组采用DA方案。结果二者缓解率上差异无显著性(P〉0.05)。两组不良反应在发热,出血,恶心、呕吐,上呼吸道感染上差异无显著性(P〉0.05),但DA较MA易出现心脏毒性,差异有显著性(P〈0.05)。结论MA可作为急非淋的一线化疗方案。

关 键 词:白血病  急性  非淋巴  米托蒽醌  柔红霉素

Clinical observation about MA and DA therapies for acute nonlymphocytic leukemia
WANG Xuan,ZHANG Hui-ying,CUI Hai-peng.Clinical observation about MA and DA therapies for acute nonlymphocytic leukemia[J].China Journal of Modern Medicine,2008,18(14).
Authors:WANG Xuan  ZHANG Hui-ying  CUI Hai-peng
Institution:WANG Xuan,ZHANG Hui-ying,CUI Hai-peng (Department of Hematology,the First Affiliated Hospital of Beihua University,Jilin,Jilin 132011,P.R.China)
Abstract:Objective] To compare the efficacy and adverse effects of DA with MA in the treatment of acute nonlymphocytic leukemia(ANLL). Methods] Case-control study was used. 60 cases of previously untreated ANLL patients were randomly divided into two groups,i.e., DA and MA treated group. 29 cases in the treatment group took MA therapy while 31 cases in the control group received DA therapy. Result] In both groups there was no significant difference in the complete remission (CR) rate and the total response rate(P...
Keywords:leukemia  acute  nonlymphocytic  Rubomycin  Mitoxantrone  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号